Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Antibodies are a wonderful example of what natural selection, operating over millions of years of evolution, can engineer. Drug developers searching for novel, non-natural antibody therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results